# Cannabis Strategic Ventures (NUGS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NUGS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2022 | $ 1.21M | $ -6.14M | $ -2.62M | $ 13.57M | $ -8.68M |
| 2021 | $ 12.46M | $ -9.13M | $ -4.85M | $ 14.30M | $ -5.19M |
| 2020 | $ 4.70M | $ -6.07M | $ -4.93M | $ 19.9K | $ -7.9K |
| 2019 | $ 3.72M | $ -32.12M | $ -12.85M | $ 19.11M | $ -2.55M |
| 2018 | $ 512.1K | $ -2.30M | $ -1.93M | $ -8.0K | $ 3.74M |
| 2017 | $ 137.7K | $ -4.73M | $ -280.1K | $ 0 | $ 3.87M |
| 2016 | $ 0 | $ 70.6K | $ -17.3K | $ 0 | $ -41.0K |
| 2015 | $ 0 | $ -4.9K | $ -236 | N/A | $ -92.0K |
| 2014 | $ 211.3K | $ 16.7K | $ 36.5K | $ 39.0K | $ -56.0K |
| 2013 | $ 344.0K | $ 64.0K | $ 21.5K | $ 178.0K | $ -178.0K |
| 2011 | $ 148.1K | $ -33.6K | $ -31.2K | $ 24.0K | $ -43.7K |
| 2006 | $ 710 | $ 4.85M | N/A | N/A | N/A |
| 2005 | $ 188.0K | $ -857.6K | N/A | N/A | N/A |
| 2004 | $ 70.1K | N/A | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -1.56 |
| Liabilities / Eq | -2.25 |
| Current Ratio | 0.13 |

## Other views

- [Metrics](https://sponda.capital/en/NUGS.md)
- [Charts](https://sponda.capital/en/NUGS/charts.md)
- [Compare](https://sponda.capital/en/NUGS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.